High Risk of Thromboembolic Events in Patients With NSCLC With ALK/ROS1 Fusions

Remotely Monitoring Patients With Cancer Has Applicability During COVID-19 Pandemic and Beyond

Implications of the PACIFIC Trial in 2020

Checkpoint Inhibitors in SCLC: Putting the Most Novel Data in Context

Multidisciplinary Tumor Boards: Integrating Best Patient Care and Education in Precision Medicine

The Rationale for Local Consolidation Therapy in Oncogene-Driven NSCLC

A Decade of Changes in Lung Cancer, with More to Come

Stage IIIA NSCLC: A Review of Recent and Ongoing Trials

Building and Maintaining a Patient–Physician Relationship in the COVID-19 Era

Multidisciplinary Tumor Board: A Single Institution’s Perspective

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic

COVID-19 and Thoracic Malignancies